StockData
Merck & Co., Inc. logo

Merck & Co., Inc. (MRK) operating KPIs

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)

Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%

Merck organon & Co. — Diluted EPS ($) ($)

Organon & Co. Form 10-Q / 10-K

QuarterlyAnnual
Latest, Q2 2026
0.40
Period ended Jun 30, 2026
Change on a year earlier
-28.6%
0.56 in Q2 2025
History
20 quarters
Since Q1 2020
Sources
17
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOrganon & Co. — Diluted EPS ($) ($)Year on yearSource
Q2 2026Jun 30, 20260.40-28.6%Organon & Co. SEC Filing (0001628280-26-051230) ↗
Q1 2026Mar 31, 20260.55+66.7%Organon & Co. SEC Filing (0001628280-26-029532) ↗
Q3 2025Sep 30, 20250.61-55.8%Organon & Co. SEC Filing (0001628280-25-050795) ↗
Q2 2025Jun 30, 20250.56-25.3%Organon & Co. SEC Filing (0001628280-26-051230) ↗
Q1 2025Mar 31, 20250.33-57.7%Organon & Co. SEC Filing (0001628280-26-029532) ↗
Q3 2024Sep 30, 20241.38+500.0%Organon & Co. SEC Filing (0001628280-25-050795) ↗
Q2 2024Jun 30, 20240.75-21.1%Organon & Co. SEC Filing (0001821825-25-000066) ↗
Q1 2024Mar 31, 20240.78+13.0%Organon & Co. SEC Filing (0001821825-25-000023) ↗
Q3 2023Sep 30, 20230.23-74.2%Organon & Co. SEC Filing (0001821825-24-000108) ↗
Q2 2023Jun 30, 20230.95+3.3%Organon & Co. SEC Filing (0001821825-24-000083) ↗
Q1 2023Mar 31, 20230.69-49.3%Organon & Co. SEC Filing (0001821825-24-000056) ↗
Q3 2022Sep 30, 20220.89-29.9%Organon & Co. SEC Filing (0001821825-23-000013) ↗
Q2 2022Jun 30, 20220.92-45.2%Organon & Co. SEC Filing (0001821825-23-000010) ↗
Q1 2022Mar 31, 20221.36-13.9%Organon & Co. SEC Filing (0001821825-23-000006) ↗
Q3 2021Sep 30, 20211.27-41.2%Organon & Co. SEC Filing (0001821825-22-000012) ↗
Q2 2021Jun 30, 20211.68-21.5%Organon & Co. SEC Filing (0001821825-22-000009) ↗

Cite this data

StockData. (2026). Merck Organon & Co. — Diluted EPS ($) ($), quarterly Q1 2020–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/ogn_eps

See every metric in the Merck KPI table. Data updated Oct 26, 2026.